IL1B and breast cancer: Others have shown that reduced mammary stroma IL-1β production and increased mammary tumor IL-1Ra levels play roles in ENL’s anti-angiogenic effects [10], suggesting that ENL has additional anti-inflammatory effects that contribute to its anti-tumor activity.